ABBOTT LABORATORIES — Director's Dealing 2017

Feb 23, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-02-17

Reporting Person: Warmuth Michael J (Executive Vice President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-17	Option (right to buy)	$44.40	A	205023	Acquired	2027-02-16	Common shares (205023)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 68,341 on 02/17/2018, 68,341 on 02/17/2019, and 68,341 on 02/17/2020.